Neurogranin as a cognitive biomarker in cerebrospinal fluid and blood exosomes for Alzheimer’s disease and mild cognitive impairment

摘要

Data include 2891 individuals from 19 studies. The squares indicate individual study SMD and their corresponding 95% CIs and the sizes of the squares are proportional to study weight. Ng neurogranin, SMD standard mean difference, CI confidence interval, AD Alzheimer’s disease, HC healthy control.